Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer treatment Calquence, GSK’s chronic obstructive pulmonary disorder (COPD) drug Breo Ellipta, and AbbVie’s antipsychotic medication Vraylar.
The list, which includes 15 drugs ... Austedo; Austedo XR, for Huntington’s disease. Breo Ellipta, a COPD drug. Tradjenta, a diabetes drug. Xifaxan, for diarrhea and irritable bowel syndrome ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback